📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Antibody combination therapy targeting CD25, CD70 and CD8 reduces islet inflammation and improves glycaemia in diabetic mice. (2012)

First Author: Alkhamis T

Attributed to: MRC Centre for Transplantation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/j.1365-2249.2012.04651.x

PubMed Identifier: 23039884

Publication URI: http://europepmc.org/abstract/MED/23039884

Type: Journal Article/Review

Volume: 170

Parent Publication: Clinical and experimental immunology

Issue: 2

ISSN: 0009-9104